These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11043492)
1. Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene. Inoue K; Yamazaki H; Shimada T Arch Toxicol; 2000 Sep; 74(7):372-8. PubMed ID: 11043492 [TBL] [Abstract][Full Text] [Related]
2. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855 [TBL] [Abstract][Full Text] [Related]
3. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Carrière V; Berthou F; Baird S; Belloc C; Beaune P; de Waziers I Pharmacogenetics; 1996 Jun; 6(3):203-11. PubMed ID: 8807659 [TBL] [Abstract][Full Text] [Related]
4. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians. Inoue K; Yamazaki H; Shimada T Arch Toxicol; 2000 Jan; 73(10-11):532-9. PubMed ID: 10663384 [TBL] [Abstract][Full Text] [Related]
5. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Shimada T; Tsumura F; Yamazaki H Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312 [TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. Kim RB; Yamazaki H; Chiba K; O'Shea D; Mimura M; Guengerich FP; Ishizaki T; Shimada T; Wilkinson GR J Pharmacol Exp Ther; 1996 Oct; 279(1):4-11. PubMed ID: 8858968 [TBL] [Abstract][Full Text] [Related]
7. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304 [TBL] [Abstract][Full Text] [Related]
8. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. McCarver DG; Byun R; Hines RN; Hichme M; Wegenek W Toxicol Appl Pharmacol; 1998 Sep; 152(1):276-81. PubMed ID: 9772223 [TBL] [Abstract][Full Text] [Related]
9. Characterization of (+/-)-bufuralol hydroxylation activities in liver microsomes of Japanese and Caucasian subjects genotyped for CYP2D6. Shimada T; Tsumura F; Yamazaki H; Guengerich FP; Inoue K Pharmacogenetics; 2001 Mar; 11(2):143-56. PubMed ID: 11266079 [TBL] [Abstract][Full Text] [Related]
10. Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. Inoue K; Yamazaki H; Imiya K; Akasaka S; Guengerich FP; Shimada T Pharmacogenetics; 1997 Apr; 7(2):103-13. PubMed ID: 9170147 [TBL] [Abstract][Full Text] [Related]
11. Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes. Draper AJ; Madan A; Latham J; Parkinson A Drug Metab Dispos; 1998 Apr; 26(4):305-12. PubMed ID: 9531516 [TBL] [Abstract][Full Text] [Related]
12. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics. Plee-Gautier E; Foresto F; Ferrara R; Bodénez P; Simon B; Manno M; Berthou F; Lucas D Alcohol Clin Exp Res; 2001 Jun; 25(6):800-4. PubMed ID: 11410713 [TBL] [Abstract][Full Text] [Related]
13. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018 [TBL] [Abstract][Full Text] [Related]
14. Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations. Shimada T; Yamazaki H; Guengerich FP Xenobiotica; 1996 Apr; 26(4):395-403. PubMed ID: 9173680 [TBL] [Abstract][Full Text] [Related]
15. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations. Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies. Yamamura Y; Koyama N; Umehara K Xenobiotica; 2015 Apr; 45(4):353-60. PubMed ID: 25815637 [TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of novel polymorphisms in the CYP2E1 gene. Fairbrother KS; Grove J; de Waziers I; Steimel DT; Day CP; Crespi CL; Daly AK Pharmacogenetics; 1998 Dec; 8(6):543-52. PubMed ID: 9918138 [TBL] [Abstract][Full Text] [Related]
18. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Marchand LL; Wilkinson GR; Wilkens LR Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):495-500. PubMed ID: 10385138 [TBL] [Abstract][Full Text] [Related]
19. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365 [TBL] [Abstract][Full Text] [Related]
20. Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women. Varela NM; Quiñones LA; Orellana M; Poniachik J; Csendes A; Smok G; Rodrigo R; Cáceres DD; Videla LA Biol Res; 2008; 41(1):81-92. PubMed ID: 18769766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]